<VariationArchive RecordType="classified" VariationID="978818" VariationName="NM_001754.5(RUNX1):c.166_196del (p.Leu56fs)" VariationType="Deletion" Accession="VCV000978818" Version="2" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2023-12-17" DateCreated="2020-10-03" MostRecentSubmission="2023-12-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="966896" VariationID="978818">
      <GeneList>
        <Gene Symbol="RUNX1" FullName="RUNX family transcription factor 1" GeneID="861" HGNC_ID="HGNC:10471" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>21q22.12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="21" Accession="NC_000021.9" start="34787801" stop="35049302" display_start="34787801" display_stop="35049302" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="21" Accession="NC_000021.8" start="36160097" stop="36421594" display_start="36160097" display_stop="36421594" Strand="-" />
          </Location>
          <OMIM>151385</OMIM>
          <Haploinsufficiency last_evaluated="2023-06-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RUNX1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-06-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RUNX1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001754.5(RUNX1):c.166_196del (p.Leu56fs)</Name>
      <CanonicalSPDI>NC_000021.9:34886997:CAGCGCCGGCGTCCGGGGCGCCCAGCGGCAAC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>21q22.12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="21" Accession="NC_000021.9" start="34886998" stop="34887028" display_start="34886998" display_stop="34887028" variantLength="31" positionVCF="34886997" referenceAlleleVCF="GCAGCGCCGGCGTCCGGGGCGCCCAGCGGCAA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="21" Accession="NC_000021.8" start="36259295" stop="36259325" display_start="36259295" display_stop="36259325" variantLength="31" positionVCF="36259294" referenceAlleleVCF="GCAGCGCCGGCGTCCGGGGCGCCCAGCGGCAA" alternateAlleleVCF="G" />
      </Location>
      <OtherNameList>
        <Name>NM_001754.5(RUNX1):c.166_196del</Name>
        <Name>p.Leu56fs</Name>
      </OtherNameList>
      <ProteinChange>L29fs</ProteinChange>
      <ProteinChange>L56fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000021.8" sequenceAccession="NC_000021" sequenceVersion="8" change="g.36259296_36259326del" Assembly="GRCh37">
            <Expression>NC_000021.8:g.36259296_36259326del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000021.9" sequenceAccession="NC_000021" sequenceVersion="9" change="g.34886999_34887029del" Assembly="GRCh38">
            <Expression>NC_000021.9:g.34886999_34887029del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011402.2" sequenceAccession="NG_011402" sequenceVersion="2" change="g.1102684_1102714del">
            <Expression>NG_011402.2:g.1102684_1102714del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001001890.3" sequenceAccession="NM_001001890" sequenceVersion="3" change="c.85_115del">
            <Expression>NM_001001890.3:c.85_115del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001001890.1" sequenceAccession="NP_001001890" sequenceVersion="1" change="p.Leu29fs">
            <Expression>NP_001001890.1:p.Leu29fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001122607.2" sequenceAccession="NM_001122607" sequenceVersion="2" change="c.85_115del">
            <Expression>NM_001122607.2:c.85_115del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001116079.1" sequenceAccession="NP_001116079" sequenceVersion="1" change="p.Leu29fs">
            <Expression>NP_001116079.1:p.Leu29fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001754.5" sequenceAccession="NM_001754" sequenceVersion="5" change="c.166_196del" MANESelect="true">
            <Expression>NM_001754.5:c.166_196del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001745.2" sequenceAccession="NP_001745" sequenceVersion="2" change="p.Leu56fs">
            <Expression>NP_001745.2:p.Leu56fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_482" sequenceAccession="LRG_482">
            <Expression>LRG_482:g.1102684_1102714del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001754.5" sequenceAccession="NM_001754" sequenceVersion="5" change="c.166_196delTTGCCGCTGGGCGCCCCGGACGCCGGCGCTG" MANESelect="true">
            <Expression>NM_001754.5:c.166_196delTTGCCGCTGGGCGCCCCGGACGCCGGCGCTG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2058002908" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001754.5(RUNX1):c.166_196del (p.Leu56fs) AND Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1" Accession="RCV001257572" Version="2">
        <ClassifiedConditionList TraitSetID="3994">
          <ClassifiedCondition DB="MedGen" ID="C1832388">Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>reviewed by expert panel</ReviewStatus>
            <Description DateLastEvaluated="2023-12-09" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-09" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2020-10-03" MostRecentSubmission="2023-12-17">
        <ReviewStatus>reviewed by expert panel</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/e04d2c7a-112a-4963-afd5-2ef16d750b0a</URL>
        </Citation>
        <ConditionList>
          <TraitSet ID="3994" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3980" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1</ElementValue>
                <XRef ID="MONDO:0100083" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial platelet disorder with associated myeloid malignancy</ElementValue>
                <XRef ID="Familial+Platelet+Disorder+with+Associated+Myeloid+Malignancy/2765" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial thrombocytopenia with propensity to acute myelogenous leukemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial Platelet Disorder with Propensity to Acute Myelogenous Leukemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Platelet disorder, Aspirin-like</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FPD/AML</ElementValue>
                <XRef Type="MIM" ID="601399" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FPDMM</ElementValue>
                <XRef Type="MIM" ID="601399" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">RUNX1 familial platelet disorder with associated myeloid malignancies (RUNX1-FPDMM) is characterized by prolonged bleeding and/or easy bruising and an increased risk of developing a hematologic malignancy. RUNX1-FPDMM is characterized by thrombocytopenia with normal platelet size; bleeding is often greater than expected due to qualitative platelet dysfunction. Myeloid malignancies are the most common, including acute myelogenous leukemia (and myelodysplastic syndrome. T- and B-cell acute lymphoblastic leukemias and lymphomas have also been reported, as well as skin manifestations (e.g., eczema, psoriasis).</Attribute>
                <XRef ID="NBK568319" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15329" />
                <XRef ID="15329" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">33661592</ID>
                <ID Source="BookShelf">NBK568319</ID>
              </Citation>
              <XRef ID="71290" DB="Orphanet" />
              <XRef ID="C1832388" DB="MedGen" />
              <XRef ID="C563324" DB="MeSH" />
              <XRef ID="MONDO:0100083" DB="MONDO" />
              <XRef Type="MIM" ID="601399" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2832658" SubmissionDate="2020-09-21" DateLastUpdated="2020-10-03" DateCreated="2020-10-03">
        <ClinVarSubmissionID localKey="SUB8181793" submittedAssembly="GRCh37" title="SUB8181793" />
        <ClinVarAccession Accession="SCV001432808" DateUpdated="2020-10-03" DateCreated="2020-10-03" Type="SCV" Version="1" SubmitterName="Malcovati Lab, University of Pavia" OrgID="507644" OrganizationCategory="laboratory" OrgAbbreviation="LML" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-09-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RUNX1">
              <Name>RUNX family transcription factor 1</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001754.5:c.166_196delTTGCCGCTGGGCGCCCCGGACGCCGGCGCTG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="601399" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8181793</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion FDARecognizedDatabase="true" ID="7814789" SubmissionDate="2023-12-11" DateLastUpdated="2023-12-17" DateCreated="2023-12-17">
        <ClinVarSubmissionID localKey="e04d2c7a-112a-4963-afd5-2ef16d750b0a" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004176236" DateUpdated="2023-12-17" DateCreated="2023-12-17" Type="SCV" Version="1" SubmitterName="ClinGen Myeloid Malignancy Variant Curation Expert Panel" OrgID="507107" OrganizationCategory="consortium" OrgAbbreviation="MyeloMalig_VCEP" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-09">
          <ReviewStatus>reviewed by expert panel</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/e04d2c7a-112a-4963-afd5-2ef16d750b0a</URL>
          </Citation>
          <Comment>The NM_001754.5(RUNX1):c.166_196del (p.Leu56ProfsTer6) variant in RUNX1 is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 4/9 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v2, v3, and v4 with at least 20x coverage (PM2_Supporting). It has been reported in a proband with thrombocytopenia and MDS/MPN-U and her "affected" sister (PMID: 37216690), as well as in 2 additional probands meeting phenotypic criteria for RUNX1 (PMID: 37406166) (PS4_Moderate, PP1 is not met). It has also been reported in a patient with MDS, but variant origin is unclear (cBioPortal.org - Papaemmanuil Lab, 2022). Furthermore, other pathogenic/likely pathogenic frameshift alterations in exon 4 have been reported (PMID: 35764482) (PM5_Supporting). In summary, this variant meets the criteria to be classified as pathogenic for autosomal dominant hereditary thrombocytopenia and hematologic cancer predisposition syndrome based on the ACMG/AMP criteria applied, as specified by the ClinGen Myeloid Malignancy VCEP: PVS1, PS4_Moderate, PM2_Supporting, and PM5_Supporting. (Version 2; date of approval)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ClinGen MyeloMalig ACMG Specifications v2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/g9fkgwq9/clingen_myelomalig_acmg_specifications_v2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RUNX1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_001754.5(RUNX1):c.166_196del</Name>
            <Name>p.Leu56fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000021.9:g.34886999_34887029del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0100083" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14033059</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2832658" TraitType="Disease" MappingType="XRef" MappingValue="601399" MappingRef="OMIM">
        <MedGen CUI="C1832388" Name="Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7814789" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0100083" MappingRef="MONDO">
        <MedGen CUI="C1832388" Name="Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

